NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
July 25, 2024 — Annovis Bio (ANVS) receives U.S. Patent No. 12,042,482 for lead drug candidate targeting neurodegenerative diseases. Exciting milestone in the development of innovative therapies with potential benefits for brain trauma victims.
July 25, 2024 — New York City's rat problem faces ethical backlash, but SenesTech's Evolve(TM) offers a sustainable solution to eliminate the rodent population.
July 25, 2024 — Mango Rx CEO discusses men's telehealth initiatives and wellness products on Benzinga's All-Access. Learn about the unique approach to men's health and wellness services.
July 25, 2024 — Benchmark International successfully facilitates the acquisition of Mideast Delivery Solutions by SPS Health, marking a significant development in the pharmaceutical and healthcare supply delivery industry.
July 25, 2024 — Leonard Mazur, CEO of Citius Pharmaceuticals, discusses the company's exciting developments and imminent drug launch in an exclusive interview with Benzinga.
July 25, 2024 — Bill Flanagan named CEO of CareWork, with leadership changes announced. Learn about the company's advanced analytics and workflow automation solutions for senior living and long-term care.
July 24, 2024 — Scinai Immunotherapeutics receives positive regulatory feedback for its plaque psoriasis clinical trial, showing potential advancements in the development of a treatment for patients with mild to moderate plaque psoriasis.
July 24, 2024 — Annovis Bio (NYSE: ANVS) announces the addition of four new members to its executive team as it makes strides towards advancing its flagship drug candidate and bringing potential treatments for neurodegenerative disorders closer to market.
July 24, 2024 — Clene presents promising findings on the potential treatment of neurodegenerative diseases like ALS with CNM-Au8(R) at the Emerging Growth Conference 73 – Biotech Feature. This groundbreaking research offers hope for patients and potential investment opportunities.
July 24, 2024 — Clene (NASDAQ: CLNN) presents new findings and information pertinent to current and potential investors in the treatment of neurodegenerative disorders like ALS and MS.
July 24, 2024 — Explore the pharmaceutical industry's relationship with Patient Advocacy Organizations & Professional Societies/Associations. Gain insights into innovative ways to improve healthcare for all patients.
July 24, 2024 — American Medical Technology Coalition launches Opioid Addiction Deterrence Task Force to combat opioid crisis through innovative medical technologies and strategic partnerships. The task force will focus on prevention, treatment, policy advocacy, and education.
July 23, 2024 — The World Health Organization and Centre for Neuro Skills provide essential tips for preventing heat-related illnesses due to rising global temperatures. Learn how to protect yourself and your loved ones from heat stroke and other heat-related illnesses.
July 23, 2024 — Dr. Paul Nassif has been recognized in Newsweek's 2024 ranking of America's Best Plastic Surgeons, showcasing his exceptional skills in facelift, rhinoplasty, and eyelid surgery. Learn more about Dr. Nassif's commitment to excellence and his innovative skincare line, NassifMD™ Skincare, offering high-quality products for maintaining healthy, youthful skin.
July 23, 2024 — New research from HR.com’s HR Research Institute reveals the effectiveness of employee well-being programs and the challenges organizations face in addressing mental health issues. The study emphasizes the importance of cohesive strategies to alleviate employee stress and enhance overall well-being.
July 23, 2024 — The Corporate Whistleblower Center is urging nursing home staff to report potential PPP loan fraud, highlighting the importance of maintaining staffing levels in healthcare facilities.
July 23, 2024 — Bethany Hall-Long's journey, experience, and vision for Delaware as the ideal candidate for Governor
July 22, 2024 — Nutriband (NASDAQ: NTRB) is set to host a live webinar on July 25, 2024, providing investors with valuable insights into the company's operations and upcoming milestones. Register for free to learn more about Nutriband's abuse-deterrent fentanyl patch and AVERSA(TM) technology.
July 22, 2024 — Annovis Bio (NYSE: ANVS) releases positive data from Phase III study of buntanetap for early Parkinson's Disease, showing effectiveness in enhancing motor and cognitive functions, as well as non-motor activities.
July 22, 2024 — PONS has been recognized with the esteemed WIPO Global Award for its dedication to innovation and robust intellectual property (IP) foundations. The award acknowledges PONS's inventive approach to making ultrasound imaging accessible and affordable for all, addressing the limited amount of diverse data available on disease progress and medical imaging challenges in rural and low-income communities.